Kyle Lefkoff, Director at ARRAY BIOPHARMA INC (ARRY), sold 100,000 shares at $17.01 ($1.7M) on 2018-02-09, disclosed to the SEC on 2018-02-12.
Open-market sale of $1.7M ARRY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.01 | 50,000 | $851K | 50.0% |
| 2 | $17.01 | 50,000 | $851K | 50.0% |
| Total | $17.01 avg | 100,000 | $1.7M | 100% |
| Filing → |
| ARRY | SELL | 2017-09-29 | $957K | — | Filing → |
| ARRY | SELL | 2017-04-04 | $401K | — | Filing → |
| MGEN | SELL | 2017-03-13 | $83K | — | Filing → |